salicylic acid has been researched along with thromboxane b2 in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (40.00) | 18.7374 |
| 1990's | 6 (24.00) | 18.2507 |
| 2000's | 5 (20.00) | 29.6817 |
| 2010's | 4 (16.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akagi, T; Inoue, O; Kato, H; Sato, N | 1 |
| Buchanan, MR; Butt, RW; Hirsh, J; Markham, BA; Nazir, DJ | 1 |
| Bucchi, F; Cerletti, C; Chen, ZM; de Gaetano, G; Gambino, MC; Gori, G; Latini, R; Passaghe, S | 1 |
| Cerletti, C; de Gaetano, G; Dejana, E; Domanin, M; Latini, R; Lauri, D; Lorenzi, G; Marchi, S; Urso, R | 1 |
| Anttila, M; Kahela, P; Uotila, P | 1 |
| Bucchi, F; Cerletti, C; de Gaetano, G | 1 |
| Chen, YC; Kuo, TL; Lee, TK | 1 |
| Ang, A; Chen, YC; Kuo, TL; Lee, TK; Lien, IN; Liu, MC | 1 |
| Cerletti, C; Costantini, V; De Amicis, G; de Gaetano, G; Dejana, E; Lorenzi, G | 1 |
| Cerletti, C; de Gaetano, G; Dejana, E; Del Maschio, A; Galletti, F; Latini, R | 1 |
| Dahl, ML; Uotila, P | 1 |
| Abdel-Rahman, MS; Rizk, M | 1 |
| Ando, F; Arakawa, M; Kambara, K; Kano, A; Ohno, M; Segawa, T | 1 |
| Fitzgerald, DJ; Keimowitz, RM; Mayo, G; Pulvermacher, G | 1 |
| Alemany, M; Bastida, E; Bozzo, J; Buchanan, MR; Hernández, R; Ordinas, A | 1 |
| Andrieu, S; Berdeaux, A; Bévérelli, F; Giudicelli, JF; Lebret, M; Maclouf, J | 1 |
| De La Cruz, JP; González-Correa, JA; Guerrero, A; Márquez, E; Martos, F; Sánchez De La Cuesta, F | 1 |
| Asai, T; Esumi, K; Fujisawa, Y; Fujita, TD; Fujita, TK; Fujiwara, T; Hashimoto, Y; Hatoyama, T; Hino, F; Hishigaki, H; Horimoto, S; Ikeda, M; Imagawa, K; Katsumata, T; Kono, M; Maeda, T; Miyajima, N; Ogawa, T; Sasaki, S; Sesoko, S; Shimada, M; Sugawara, T; Suzuki, E; Suzuki, M; Tokushige, H; Tsuzuki, Y; Yamamoto, T; Zaima, H | 1 |
| Cerletti, C; Crescente, M; de Gaetano, G | 1 |
| De La Cruz, JP; González-Correa, JA; Guerrero, A; López-Villodres, JA; Muñoz-Marín, J; Navas, MD; Torres, JA | 1 |
| Choi, CI; Gao, L; Joseph, S; Kopelovich, L; Patlolla, JM; Rao, CV; Rigas, B; Steele, VE | 1 |
| Boutaud, O; Oates, JA | 1 |
| Barbarulo, A; Felli, MP; Frati, L; Gaudio, C; Gazzaniga, P; Guerriero, R; Lotti, LV; Mattiello, T; Pucci, B; Pulcinelli, FM; Trifirò, E | 1 |
| Hoshina, K; Manita, S; Matsuzawa, S; Miyata, Y; Ooie, T; Sasahara, T; Sueyoshi, S; Yasue, T | 1 |
| Czlonkowski, A; Filipiak, KJ; Grygorowicz, T; Janicki, PK; Kaplon-Cieslicka, A; Opolski, G; Postula, M; Przybylkowski, A; Rosiak, M; Trzepla, E | 1 |
3 trial(s) available for salicylic acid and thromboxane b2
| Article | Year |
|---|---|
Salicylate treatment in Kawasaki disease: high dose or low dose?
Topics: 6-Ketoprostaglandin F1 alpha; Alanine Transaminase; Child, Preschool; Dose-Response Relationship, Drug; Female; Fever; Humans; Infant; Male; Mucocutaneous Lymph Node Syndrome; Salicylates; Salicylic Acid; Thromboxane B2 | 1991 |
Differences in the effects of extended-release aspirin and plain-formulated aspirin on prostanoids and nitric oxide in healthy volunteers.
Topics: Adult; Aspirin; Cross-Over Studies; Delayed-Action Preparations; Dinoprost; Double-Blind Method; Epoprostenol; Female; Humans; Male; Nitric Oxide; Platelet Aggregation Inhibitors; Salicylic Acid; Thromboxane B2 | 2003 |
Exploratory aspirin resistance trial in healthy Japanese volunteers (J-ART) using platelet aggregation as a measure of thrombogenicity.
Topics: Adult; Asian People; Aspirin; Drug Resistance; Gene Frequency; Genotype; Humans; Japan; Male; Membrane Glycoproteins; Membrane Proteins; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Polymorphism, Single Nucleotide; Receptors, Thromboxane A2, Prostaglandin H2; Reference Values; Salicylic Acid; Thromboxane B2 | 2007 |
22 other study(ies) available for salicylic acid and thromboxane b2
| Article | Year |
|---|---|
Role of lipoxygenase metabolism in platelet function: effect of aspirin and salicylate.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; 5,8,11,14-Eicosatetraynoic Acid; Aspirin; Blood Platelets; Collagen; Humans; Hydroxyeicosatetraenoic Acids; Lipoxygenase; Platelet Adhesiveness; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Salicylates; Salicylic Acid; Thromboxane B2 | 1986 |
Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Animals; Aspirin; Blood Platelets; Blood Vessels; Cyclooxygenase Inhibitors; Gastric Mucosa; Liver; Male; Portacaval Shunt, Surgical; Rats; Salicylates; Salicylic Acid; Thromboxane B2; Time Factors | 1988 |
Pharmacokinetics of enteric-coated aspirin and inhibition of platelet thromboxane A2 and vascular prostacyclin generation in humans.
Topics: Adult; Aspirin; Blood Platelets; Epoprostenol; Female; Humans; Kinetics; Salicylates; Salicylic Acid; Saphenous Vein; Tablets, Enteric-Coated; Thromboxane A2; Thromboxane B2 | 1987 |
The absorption of acetylsalicylic acid from an enteric-coated formulation and the inhibition of thromboxane formation.
Topics: Adult; Aspirin; Depression, Chemical; Female; Half-Life; Humans; Intestinal Absorption; Male; Salicylates; Salicylic Acid; Tablets; Tablets, Enteric-Coated; Thromboxane B2; Thromboxanes | 1988 |
Salicylate may prevent the inhibitory effect of indomethacin on serum thromboxane formation in man.
Topics: Adult; Female; Humans; Indomethacin; Male; Salicylates; Salicylic Acid; Thromboxane B2 | 1986 |
Comparison of the effect of acetylsalicylic acid on platelet function in male and female patients with ischemic stroke.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Aged; Aspirin; Blood Platelets; Brain Ischemia; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Platelet Aggregation; Salicylates; Salicylic Acid; Sex Factors; Thromboxane B2 | 1987 |
Studies of platelet hyperactivity in patients with ischemic cerebrovascular diseases: IV. Determination of the optimal dosage of aspirin by measuring plasma salicylate level.
Topics: Aged; Aspirin; Blood Platelets; Brain Ischemia; Female; Humans; Male; Middle Aged; Salicylates; Salicylic Acid; Thromboxane B2 | 1987 |
Differential salicylate-aspirin interaction on vascular prostacyclin and platelet thromboxane synthesis in patients undergoing saphenectomy.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Blood Platelets; Drug Interactions; Female; Humans; Middle Aged; Salicylates; Salicylic Acid; Thromboxane B2; Varicose Veins; Veins | 1985 |
Aspirin kinetics and inhibition of platelet thromboxane generation-relevance for a solution of the "aspirin dilemma".
Topics: Adult; Aspirin; Blood Platelets; Capsules; Humans; Kinetics; Male; Salicylates; Salicylic Acid; Tablets; Thromboxane B2 | 1985 |
Salicylate does not interfere with aspirin in human blood in vivo.
Topics: Adult; Aspirin; Blood Coagulation; Blood Platelets; Humans; Male; Salicylates; Salicylic Acid; Thromboxane B2; Thromboxanes | 1984 |
Salicylamide reverses the aspirin-antagonistic effect of salicylic acid on rat platelet cyclooxygenase.
Topics: Animals; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Male; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Salicylamides; Salicylates; Salicylic Acid; Thromboxane B2 | 1994 |
Effects of acetylsalicylic acid on pulmonary vascular tone and membrane permeability in blood-perfused dog lung.
Topics: 6-Ketoprostaglandin F1 alpha; Airway Resistance; Animals; Aspirin; Blood Pressure; Capillary Permeability; Dogs; Extravascular Lung Water; Female; Leukotrienes; Male; Muscle, Smooth, Vascular; Organ Size; Perfusion; Pulmonary Circulation; Salicylates; Salicylic Acid; Thromboxane B2; Vascular Resistance | 1993 |
Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis.
Topics: Administration, Cutaneous; Adult; Aspirin; Blood Platelets; Bradykinin; Cyclooxygenase Inhibitors; Epoprostenol; Female; Humans; Male; Middle Aged; Salicylates; Salicylic Acid; Thromboxane B2 | 1993 |
Platelet adhesivity to subendothelium is influenced by polymorphonuclear leukocytes: studies with aspirin and salicylate.
Topics: 6-Ketoprostaglandin F1 alpha; Alprostadil; Animals; Aspirin; Blood Platelets; Cell Communication; Cyclooxygenase Inhibitors; Endothelium, Vascular; Humans; Lipoxygenase Inhibitors; Neutrophils; Platelet Adhesiveness; Rabbits; Salicylates; Salicylic Acid; Thromboxane B2 | 1993 |
Effects of antiaggregant and antiinflammatory doses of aspirin on coronary hemodynamics and myocardial reactive hyperemia in conscious dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Bradykinin; Coronary Disease; Coronary Vessels; Cyclooxygenase Inhibitors; Diclofenac; Dogs; Dose-Response Relationship, Drug; Hyperemia; Male; Myocardium; Nitric Oxide Synthase; Nitroarginine; Salicylic Acid; Thromboxane B2; Time Factors | 1999 |
Gallic acid, a dietary polyphenolic component, blunts the inhibition of platelet COX-1 by aspirin: preliminary in-vitro findings.
Topics: Aspirin; Blood Platelets; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Food-Drug Interactions; Gallic Acid; Humans; In Vitro Techniques; Platelet Aggregation; Salicylic Acid; Thromboxane B2 | 2007 |
Differences in the influence of the interaction between acetylsalicylic acid and salicylic acid on platelet function in whole blood and isolated platelets: influence of neutrophils.
Topics: Adult; Aspirin; Blood Platelets; Dose-Response Relationship, Drug; Drug Interactions; Humans; In Vitro Techniques; Male; Neutrophils; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Salicylic Acid; Thromboxane B2 | 2007 |
Pharmacokinetic and pharmacodynamic study of NO-donating aspirin in F344 rats.
Topics: Animal Feed; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colon; Drug Evaluation, Preclinical; Eicosanoids; Male; Nitric Oxide; Rats; Rats, Inbred F344; Salicylic Acid; Thromboxane B2; Time Factors | 2008 |
Study of inhibitors of the PGH synthases for which potency is regulated by the redox state of the enzymes.
Topics: Acetaminophen; Animals; Arachidonic Acid; Aspirin; Blood Platelets; Cell Line, Tumor; Cyclooxygenase Inhibitors; Dinoprostone; Gas Chromatography-Mass Spectrometry; Humans; Hydrogen Peroxide; Mice; Oxidation-Reduction; Prostaglandin-Endoperoxide Synthases; Salicylic Acid; Thromboxane B2 | 2010 |
Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting.
Topics: Adult; Aspirin; Biological Transport; Blood Platelets; Cells, Cultured; Coronary Artery Bypass; Cyclic AMP; Cyclooxygenase 1; Dinoprostone; Drug Interactions; Drug Resistance; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Propionates; Prostaglandin-Endoperoxide Synthases; Quinolines; RNA, Small Interfering; Salicylic Acid; Thromboxane B2 | 2011 |
Ibudilast, a phosphodiesterase inhibitor, in combination with low-dose aspirin potently inhibits guinea pig carotid artery thrombosis without extending bleeding time and causing gastric mucosal injury.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Bleeding Time; Carotid Artery Thrombosis; Drug Therapy, Combination; Gastric Mucosa; Guinea Pigs; Immunoenzyme Techniques; Indicators and Reagents; Male; Mice; Phosphodiesterase Inhibitors; Photochemistry; Platelet Aggregation Inhibitors; Pyridines; Rolipram; Salicylic Acid; Stomach Diseases; Thromboxane B2 | 2012 |
Association of plasma concentrations of salicylic acid and high on ASA platelet reactivity in type 2 diabetes patients.
Topics: Aged; Aspirin; Biomarkers; Blood Platelets; Chromatography, High Pressure Liquid; Coronary Artery Disease; Cyclooxygenase 1; Diabetes Mellitus, Type 2; Drug Resistance; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Platelet Function Tests; Poland; Predictive Value of Tests; Prospective Studies; Risk Factors; Salicylic Acid; Thromboxane B2 | 2013 |